{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:05:42Z","timestamp":1789189542976,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.anai.2026.07.026","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:28:52Z","timestamp":1785799732000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improved peripheral airway reactance is associated with clinical remission after biologic therapy in severe asthma"],"prefix":"10.1016","author":[{"given":"Jo Vi","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lipworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Menzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Cottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Poto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Diamant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Suter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Portacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Adcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"McGinty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Fardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2805-8266","authenticated-orcid":false,"given":"Rory","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anai.2026.07.026_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4168\/aair.2026.18.1.19","article-title":"Precision Medicine for asthma: tailored to its severity and endotype\/phenotype","volume":"18","author":"Chan","year":"2026","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.anai.2026.07.026_bib0002","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(24)00293-5","article-title":"Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis","volume":"13","author":"Shackleford","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.anai.2026.07.026_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.103050","article-title":"Roads to remission: evolving treatment concepts in type 2 inflammatory diseases","volume":"80","author":"Lommatzsch","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.anai.2026.07.026_bib0004","doi-asserted-by":"crossref","unstructured":"Kumar A, Chan R, Zounemat-Kermani N, Quek E, Adcock IM, Beghe B, et al. Small airways dysfunction and remission in adults with asthma: a longitudinal exploratory analysis of the AssessmenT of smalL airways involvemeNT in aSthma (ATLANTIS) study [e-pub ahead of print]. Allergy. https:\/\/doi.org\/10.1111\/all.70264, Accessed May 1, 2026.","DOI":"10.1111\/all.70264"},{"issue":"5","key":"10.1016\/j.anai.2026.07.026_bib0005","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.chest.2024.12.020","article-title":"Ascertainment of small airways dysfunction using oscillometry to better define asthma control and future risk: are we ready to implement it in clinical practice?","volume":"167","author":"Chan","year":"2025","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.anai.2026.07.026_bib0006","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2025.06.037","article-title":"Effect of dupilumab on small airways measured by airway oscillometry in VESTIGE","volume":"156","author":"Washko","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2026.07.026_bib0007","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.anai.2025.01.024","article-title":"Real world effects of tezepelumab on small airways dysfunction in severe refractory asthma","volume":"134","author":"Greig","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"10.1016\/j.anai.2026.07.026_bib0008","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2026.07.026_bib0009","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00753-2019","article-title":"Technical standards for respiratory oscillometry","volume":"55","author":"King","year":"2020","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.anai.2026.07.026_bib0010","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2026.07.026_bib0011","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.anai.2026.07.026_bib0012","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.anai.2026.07.026_bib0013","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/all.16590","article-title":"Clinical and biological remission with tezepelumab: the real-world response in severe uncontrolled asthma","volume":"80","author":"Gates","year":"2025","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2026.07.026_bib0014","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.anai.2024.11.006","article-title":"Oscillometry-defined small airways dysfunction as a treatable trait in asthma","volume":"134","author":"Cottini","year":"2025","journal-title":"Ann Allergy Asthma Immunol."},{"issue":"5","key":"10.1016\/j.anai.2026.07.026_bib0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.anai.2023.07.021","article-title":"Real-life effects of dupilumab on airway oscillometry in severe uncontrolled asthma","volume":"131","author":"Chan","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.07.026_bib0016","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/cea.70002","article-title":"Evaluation of small airways dysfunction with dupilumab using airway oscillometry in uncontrolled severe asthma","volume":"55","author":"Stewart","year":"2025","journal-title":"Clin Exp Allergy"},{"issue":"9","key":"10.1016\/j.anai.2026.07.026_bib0017","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.202306-1102LE","article-title":"Effects of dupilumab on mucus plugging and ventilation defects in patients with moderate-to-severe asthma: a randomized, double-blind, placebo-controlled trial","volume":"208","author":"Svenningsen","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2026.07.026_bib0018","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.70147","article-title":"Tezepelumab improves small airways dysfunction in severe asthma: a 52-week real-world study","volume":"16","author":"Menzella","year":"2026","journal-title":"Clin Transl Allergy"},{"issue":"5","key":"10.1016\/j.anai.2026.07.026_bib0019","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.anai.2024.02.006","article-title":"Improved small airway dysfunction in severe asthma with clinical remission by anti-interleukin-5\/interleukin-5 receptor \u03b1","volume":"132","author":"Akamatsu","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.07.026_bib0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s41030-026-00353-2","article-title":"Small airways disease adversely impacts the response to biologic therapies in severe asthma","volume":"12","author":"Allegrini","year":"2026","journal-title":"Pulm Ther"},{"issue":"1","key":"10.1016\/j.anai.2026.07.026_bib0021","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2332\/allergolint.09-OA-0122","article-title":"Comparison of effectiveness in ciclesonide and fluticasone propionate on small airway function in mild asthma","volume":"59","author":"Hoshino","year":"2010","journal-title":"Allergol Int"},{"issue":"1","key":"10.1016\/j.anai.2026.07.026_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2022.09.008","article-title":"Clinical associations of mucus plugging in moderate to severe asthma","volume":"11","author":"Chan","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2026.07.026_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.11.036","article-title":"Does size really matter?: relationship of particle size to lung deposition and exhaled fraction","volume":"139","author":"Jabbal","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.07.026_bib0024","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.chest.2023.10.046","article-title":"Clinical response and remission in patients with severe asthma treated with biologic therapies","volume":"165","author":"Hansen","year":"2024","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.anai.2026.07.026_bib0025","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jaip.2025.04.043","article-title":"RReappraisal of Biologic Efficacy from Phase 3 Trials in Refractory Chronic Rhinosinusitis and Nasal Polyps","volume":"13","author":"Lipworth","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2026.07.026_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2022.11.043","article-title":"Baseline FeNO independently predicts the dupilumab response in patients with moderate-to-severe asthma","volume":"11","author":"Pavord","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2026.07.026_bib0027","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/all.16425","article-title":"Early reduction of FeNO on anti-IL5 biologics is associated with clinical remission of severe asthma","volume":"80","author":"Soendergaard","year":"2025","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2026.07.026_bib0028","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2213-2600(25)00037-2","article-title":"Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials","volume":"13","author":"Meulmeester","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.anai.2026.07.026_bib0029","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.anai.2021.06.007","article-title":"Impact of nasal polyps on endotype and phenotype in patients with moderate to severe asthma","volume":"127","author":"Chan","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2026.07.026_bib0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00408-019-00247-y","article-title":"I say IOS you say AOS: comparative bias in respiratory impedance measurements","volume":"197","author":"Kuo","year":"2019","journal-title":"Lung"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626003649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626003649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:09:04Z","timestamp":1789186144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120626003649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"alternative-id":["S1081120626003649"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2026.07.026","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved peripheral airway reactance is associated with clinical remission after biologic therapy in severe asthma","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2026.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}